| Name | Title | Contact Details |
|---|---|---|
Justin Hansen |
Senior Director of Information Technology and Health Information Management | Profile |
ServRx is a leading national workers` compensation prescription drug claims processing company. With a strong backbone of proprietary IT and decades of experience in the workers` compensation space, ServRx serves a rapidly growing share of community and independent pharmacies. Across America, each pharmacy client is as unique as the injured workers they treat. ServRx prides itself on creating customized solutions to meet the needs of our diverse client-base. Rural mom-and-pop pharmacies, regional chains, specialty pharmacies, and large pharmacy management firms alike have turned to ServRx to handle the unique workflow and cash-flow challenges posed by workers` compensation. A winning mix of experience, technology, and economies of scale allows ServRx to promise its clients superior handling of their workers` compensation claims. Whether they process one pharmacy claim per week, or hundreds per day, ServRx clients have something in common: peace of mind and increased profitability.
Thermo Fisher Scientific Inc is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
Rafael Holdings is focused on the development of novel cancer therapies. The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the company is developing a pipeline of compounds focused on the regulation of cancer metabolism.
MyDental360 - Know what matters. Find what works. Powered by Kulzer The information you want on the subjects that affect your everyday work. We cover them from every angle—in a concise view delivered right to your inbox. Your Benefits • Busine...
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it`s Series B financing round which will support the advancement of Edgewise Therapeutic`s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company`s pipeline. The company`s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.